ALKERMES REPORTS BIG DECREASE IN NET LOSS FOR FISCAL YEAR.(Brief
Article)(Statistical Data Included)
Alkermes, Inc. (NASDAQ:ALKS), Cambridge, Mass., has reported that
the net loss for the fiscal year ended March 31 2001 was $16.9 million
as compared to a net loss of $68.0 million in the prior . . .
ALLERGAN REPORTS FIRST QTR. 8.8% INCREASE IN WORLDWIDE
SALES.(broken down by various product lines)(Statistical Data
Included)
Allergan, Inc. (NYSE:AGN), Irvine, Calif., has announced worldwide
sales increased by 8.8 percent or $33.0 million over the first quarter
last year, at constant currency rates. Including the . . .
FIRST QTR. REVENUES AND NET INCOME UP FOR THERAGENICS.(Brief
Article)(Statistical Data Included)
Theragenics Corporation (NYSE: TGX), the Buford, Georgia-based
cancer treatment producer, has announced revenue and earnings for the
first quarter ending March 31, 2001.
Revenues for the quarter . . .
HYCOR BIOMEDICAL REPORTS 7TH CONSECUTIVE PROFITABLE QTR.(Brief
Article)(Statistical Data Included)
Hycor Biomedical Inc. (NASDAQ:HYBD), Garden Grove, Calif., has
reported results for first quarter 2001.
Sales for the three months ended March 31, 2001, were $4,280,000,
compared with sales of . . .
CORIXA REPORTS STRONG FIRST QUARTER RESULTS.(includes program
updates)(Statistical Data Included)
Corixa Corporation (Nasdaq: CRXA), Seattle, a developer of
immunotherapeutics, has announced results for the first quarter ended
March 31, 2001.
For the first quarter, Corixa reported total . . .
CARDIAC SCIENCE REPORTS RECORD 2000 REVENUE OF $4.2
MILLION.(Brief Article)
Cardiac Science Inc. (Nasdaq:DFIB), Irvine, Calif., the developer
of the Powerheart(R), the only hospital monitor that provides
life-saving defibrillation within seconds and without the aid . . .
EMBREX REPORTS REVENUE INCREASES FOR 4TH QTR/YEAR 2000.(Brief
Article)(Statistical Data Included)
Embrex, Inc., Research Triangle, N.C., (Nasdaq: EMBX) has
announced revenues and earnings for the fourth quarter and the year
ended December 31, 2000.
In the course of performing its year-end . . .
NATROL LOSES $5.2 MILLION ON NET REVENUE OF $87.1 MILLION.(Brief
Article)
Natrol Inc. (Nasdaq:NTOL), Chatsworth, Calif., has announced that
it has lost $5.2 million on net revenue of $87.1 million for the year
ended Dec. 31, 2000.
Net revenue in 2000 increased 6.7%, . . .
COLUMBIA LABS REPORTS NET LOSS FOR YEAR-END 2000.(Brief
Article)(Statistical Data Included)
Columbia Laboratories (AMEX:COB), New York, has reported income of
$207,392 or $.01 per share on sales of $3,953,257 for the three months
ended December 31, 2000 as compared to a net loss of . . .
BIOPOOL/XTRANA REPORTS 11% SALES INCREASE AND NET LOSS.(Brief
Article)(Statistical Data Included)
Biopool International Inc./Xtrana (OTCBB:BIPL), Ventura, Calif.,
has reported results for the year and fourth quarter ended Dec. 31,
2000.
2000 sales from continuing operations increased 11 . . .
ORASURE'S REVENUES INCREASE FOR 4TH QTR/YEAR 2000.
OraSure Technologies, Inc. (Nasdaq:OSUR), Bethlehem, Pa., the
market leader for oral fluid diagnostics of infectious disease and
drugs-of-abuse, has announced its fourth quarter and full- . . .
TELIK REPORTS NET LOSSES FOR FOURTH QTR AND YEAR END
2000.
Telik, Inc. (Nasdaq:TELK), South San Francisco, has reported
financial results for the fourth fiscal quarter and year ended December
31, 2000.
Telik reported a net loss of $2.2 million, or $0.10 . . .
NEXELL'S ANNUAL REVENUE INCREASED 22% FOR 2000.
Nexell Therapeutics Inc. (Nasdaq:NEXL), Irvine, Calif. has
announced that its annual revenue increased to $18.2 million in 2000.
For the year ended December 31, 2000, total revenues increased . . .
APPLIED BIOSYSTEMS REPORTS 30% INCREASE IN 2ND QTR
EARNINGS.(Brief Article)
Applied Biosystems Group (NYSE:ABI), Foster City, Calif., a
business of Applera Corporation, has reported that earnings per share in
the second quarter of fiscal 2001, ended December 31, 2000, . . .
PHARSIGHT REVENUES INCREASE 52% FOR 3RD QUARTER.(Pharsight Corp.,
fiscal year 2001)(Brief Article)(Company Profile)(Statistical
Pharsight Corporation (Nasdaq:PHST), Mountain View, Calif., a
leading provider of technologies and services that improve the drug
development process, has announced results for the third quarter . . .
CELERA GENOMICS REPORTS $20.3 MILLION 2ND QTR REVENUES.(Brief
Article)
Celera Genomics Group (NYSE:CRA), Rockville, Md., a business of
Applera Corporation, has reported results for its second fiscal quarter
ended December 31, 2000. The Group's revenues for the . . .
SIMULATIONS PLUS REPORTS 30% INCREASE IN FIRST QUARTER
2001.(sales information)(Brief Article)(Statistical Data
Included)
Simulations Plus Inc. (OTCBB:SIMU) (www.simulations-plus.com), a
provider of ADME neural net and absorption simulation software for
pharmaceutical discovery and development, has reported its . . .
VASOMEDICAL REPORTS 118% NET INCOME INCREASE IN SECOND
QUARTER.(sales information)(Brief Article)(Statistical Data
Included)
Vasomedical, Inc. (Nasdaq: VASO) has reported that its net income
for the fiscal 2001 second quarter rose to $1.7 million, or $0.03 per
share, versus net income of $54,000, or nil per share, for . . .
FORBES MEDI-TECH REPORTS 1ST QTR NET LOSS OF $0.17 PER
SHARE.(profit information)(Brief Article)(Statistical Data
Included)
Forbes Medi-Tech (Nasdaq:FMTI)(TSE:FMI.) has reported its
financial results for the first quarter of fiscal 2001 ending October
31, 2000.
The company incurred a net loss for the fiscal first . . .
ORGANOGENESIS 4TH QUARTER APLIGRAF SALES SURPASS 4000
UNITS.(sales information)(Brief Article)(Statistical Data
Included)
Organogenesis Inc. (AMEX:ORG) has reported that US commercial
sales of lead product Apligraf reached 4084 units for the fourth quarter
of 2000, up from 3232 units for the previous quarter. This . . .
|
|